This is a standard proxy filing with no material financial disclosures or significant corporate actions. Monitor for any shareholder activism or voting results from the annual meeting, but no immediate trading implications.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Apr 27 $3.47entry
- T+1 · 7mo ago +4.32%α +4.81% · $3.62
- T+5 · 7mo ago +14.99%α +14.59% · $3.99
- T+20 · 6mo ago +10.37%α +5.42% · $3.83
- T+60 · 4mo ago +60.52%α +55.74% · $5.57
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Evolent Health, Inc. (EVH) has filed a definitive proxy statement (DEFA14A) for its 2026 Annual Meeting, scheduled for June 4, 2026. The filing outlines four proposals for shareholder vote: election of 10 directors, ratification of Deloitte & Touche LLP as independent auditors, approval of executive compensation, and an amendment to the 2015 Omnibus Incentive Compensation Plan. The filing is routine and does not contain any material financial disclosures or significant corporate actions.
Key Financial Metrics
Key Facts
- Filing is a definitive proxy statement (DEFA14A) for Evolent Health's 2026 Annual Meeting
- Meeting date is June 4, 2026, with voting deadline of June 3, 2026
- Four proposals to be voted on: 1) Election of 10 directors, 2) Ratification of Deloitte & Touche LLP as independent auditors, 3) Approval of executive compensation, 4) Amendment to 2015 Omnibus Incentive Compensation Plan
- No material financial information, guidance, or significant corporate actions disclosed
- Filing is routine and required by SEC regulations for annual shareholder meetings
Financial Impact
No financial impact - this is a routine proxy filing with no material financial disclosures
Risk Factors
- Low risk - this is a routine filing with no material disclosures
- Potential for shareholder activism if any of the proposals receive significant opposition
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-177275 |
| Document: 0001193125-26-177275-index-headers.html | 0001193125-26-177275 |
| Document: 0001193125-26-177275-index.html | 0001193125-26-177275 |
| Document: 0001193125-26-177275.txt | 0001193125-26-177275 |
Track record
8 reports on EVH
Filters
- Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $4.82 Now $4.83 −0.31% settles Dec 15
- Nov 13, 20263d ago SC 13G/A Bearish 5/10 Entry $4.74 Now $4.83 −1.90% settles Dec 15
- Nov 5, 202611d ago 8-K Neutral 5/10 No price data
- Nov 5, 202611d ago Press Release Neutral 5/10 Entry $4.54 Now $4.83 +6.39% settles Dec 4
- Aug 6, 202614w ago 8-K Mixed 6/10 Entry $3.59 to $4.26 Now $4.83 +34.54% ▲ +18.66% +18.06% vs SPY
- Jul 8, 202618w ago Press Release Neutral 1/10 Entry $5.63 to $3.59 Now $4.83 −14.21% ▼ −36.23% −38.48% vs SPY
- Apr 24, 202629w ago DEFA14A Neutral 2/10 Viewing Entry $3.47 to $3.83 Now $4.83 +39.19% ▲ +10.37% +5.42% vs SPY
- Feb 24, 202637w ago 8-K Mixed 6/10 Entry $3.14 to $2.27 Now $4.83 +53.82% ▼ −27.71% −22.47% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers